Evidence map›Paper›PMID 39830902›Full record

ArticleACS applied nano materials2024

Design and Characterization of a Gene-Encoding DNA Nanoparticle in a Cell-Free Transcription-Translation System.

Angelica Rose Galvan, Christopher M Green, Shelby L Hooe, Esra Oktay, Meghna Thakur, Sebastián A Díaz, Remi Veneziano, Igor L Medintz, Divita Mathur

Abstract read
In one paragraph

Article in ACS applied nano materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Plugging synthetic DNA nanoparticles into the central dogma of life.Chemical communications (Cambridge, England) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angelica Rose GalvanCenter for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States; Fischell Department of Bioengineering, College of Engineering, University of Maryland, College Park, Maryland 20742, United States.
Christopher M GreenCenter for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States.ORCID 0000-0001-7848-7144
Shelby L HooeCenter for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States.
Esra OktayDepartment of Bioengineering College of Engineering and Computing, George Mason University, Manassas, Virginia 20110, United States; Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, University of Heidelberg, Center for Integrative Infectious Diseases Research (CIID), 69120 Heidelberg, Germany.
Meghna ThakurCenter for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States; College of Science, George Mason University, Fairfax, Virginia 22030, United States.
Sebastián A DíazCenter for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States.ORCID 0000-0002-5568-0512
Remi VenezianoDepartment of Bioengineering College of Engineering and Computing, George Mason University, Manassas, Virginia 20110, United States.ORCID 0000-0002-2726-3770
Igor L MedintzCenter for Bio/Molecular Science and Engineering, Code 6900, U.S. Naval Research Laboratory, Washington, D.C. 20375, United States.ORCID 0000-0002-8902-4687
Divita MathurDepartment of Chemistry, College of Arts and Sciences, Case Western Reserve University, Cleveland, Ohio 44106, United States.ORCID 0000-0002-3537-7292

Funding

Cytosolic Access and Instability of DNA nanoparticlesR00EB030013 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI MATHUR, DIVITA · 2022 to 2024
$747k
NIBIB NIH HHS R00 EB030013
6 · The paper itself

Abstract

DNA nanotechnology has made initial progress toward developing gene-encoded DNA origami nanoparticles (NPs) that display potential utility for future gene therapy applications. However, due to the challenges involved with gene delivery into cells including transport through the membrane, intracellular targeting, and inherent expression of nucleases along with interference from other active proteins, it can be difficult to more directly study the effect of DNA NP design on subsequent gene expression. In this work, we demonstrate an approach for studying the expression of gene-encoding DNA origami NPs without the use of cells. We utilize a pure

Indexed as

DNA nanotechnologyDNA origamigene expressionluciferase cell-freepromoter sequenceT7 promotertranscription–translation systemTXTL

Identifiers

PMID39830902
PMCPMC11741557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.